|
CA2180954C
(en)
|
1994-01-11 |
2007-03-20 |
William Markland |
Inhibitors of human plasmin derived from the kunitz domains
|
|
US7129061B1
(en)
*
|
1996-08-07 |
2006-10-31 |
Biogen Idec Ma Inc. |
Tumor necrosis factor related ligand
|
|
US6494879B2
(en)
|
1998-10-15 |
2002-12-17 |
Scimed Life Systems, Inc. |
Treating urinary retention
|
|
US20160287708A9
(en)
*
|
2000-03-15 |
2016-10-06 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20050271701A1
(en)
*
|
2000-03-15 |
2005-12-08 |
Orbus Medical Technologies, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US7317075B2
(en)
*
|
2000-07-20 |
2008-01-08 |
Genentech, Inc. |
PRO21384 polypeptides
|
|
US20030100723A1
(en)
*
|
2000-07-26 |
2003-05-29 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
DE10054055A1
(en)
*
|
2000-10-31 |
2002-05-23 |
Nmi Univ Tuebingen |
Methods for analyzing proteins
|
|
US7054758B2
(en)
*
|
2001-01-30 |
2006-05-30 |
Sciona Limited |
Computer-assisted means for assessing lifestyle risk factors
|
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
US7658924B2
(en)
*
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
US7521053B2
(en)
*
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
ATE367438T1
(en)
*
|
2001-11-30 |
2007-08-15 |
Applied Research Systems |
METHOD FOR INCREASE HUMAN TNF RECEPTOR EXPRESSION
|
|
US7618788B2
(en)
*
|
2002-05-10 |
2009-11-17 |
Millipore Corporation |
Proteome epitope tags and methods of use thereof in protein modification analysis
|
|
PT1565489E
(en)
|
2002-06-19 |
2011-02-23 |
Raven Biotechnologies Inc |
SPECIFIC INTERNALIZING ANTIBODIES FOR THE RAAG10 CELL SURFACE TARGET
|
|
US20040049484A1
(en)
*
|
2002-09-11 |
2004-03-11 |
Hamano Life Science Research Foundation |
Method and apparatus for separating and extracting information on physiological functions
|
|
CA2514873C
(en)
*
|
2002-12-13 |
2012-01-03 |
David Waisman |
Compositions and methods for inhibiting tumor growth and metastasis
|
|
CN1756559B
(en)
*
|
2003-01-08 |
2010-04-28 |
诺华疫苗和诊断公司 |
Stable liquid composition comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variant
|
|
WO2004065613A2
(en)
*
|
2003-01-17 |
2004-08-05 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
|
|
WO2004073733A1
(en)
*
|
2003-02-24 |
2004-09-02 |
Morinaga Milk Industry Co., Ltd. |
Interleukin 6 production inhibitor
|
|
JP5392980B2
(en)
*
|
2003-03-27 |
2014-01-22 |
チルドレンズ ホスピタル メディカル センター |
Method and kit for detecting early-onset renal tubular cell injury
|
|
US7134459B2
(en)
*
|
2003-06-12 |
2006-11-14 |
Symyx Technologies, Inc. |
Methods and apparatus for mixing powdered samples
|
|
WO2005019434A2
(en)
|
2003-08-26 |
2005-03-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Serine protease inhibitors for treatment of bacterial infections
|
|
EP1519194A1
(en)
*
|
2003-09-24 |
2005-03-30 |
Roche Diagnostics GmbH |
Use of gfap for identification of intracerebral hemorrhage
|
|
WO2005030244A1
(en)
*
|
2003-09-30 |
2005-04-07 |
Snow Brand Milk Products Co., Ltd. |
Agent for promoting osteogenesis and/or inhibiting bone resorption
|
|
AU2004290049B2
(en)
*
|
2003-11-12 |
2011-09-29 |
The Regents Of The University Of Colorado |
Compositions and methods for regulation of tumor necrosis factor-alpha
|
|
US7332179B2
(en)
|
2003-12-12 |
2008-02-19 |
Kimberly-Clark Worldwide, Inc. |
Tissue products comprising a cleansing composition
|
|
EP1730286A4
(en)
*
|
2004-03-04 |
2007-09-05 |
Massachusetts Inst Technology |
ANTICANCER TREATMENT BASED ON DNA
|
|
JP2007530538A
(en)
*
|
2004-03-25 |
2007-11-01 |
セントカー・インコーポレーテツド |
Use of EMMPRIN antagonists for the treatment of diseases associated with hypervascularization
|
|
EP1614755A1
(en)
*
|
2004-07-07 |
2006-01-11 |
ARTEMIS Pharmaceuticals GmbH |
Target transgenesis of short hairpin RNA expression cassette using recombinase mediated cassette exchange
|
|
CA2574777C
(en)
|
2004-07-23 |
2015-09-01 |
Acceleron Pharma Inc. |
Actrii receptor polypeptides, methods and compositions
|
|
IL163453A0
(en)
*
|
2004-08-10 |
2009-02-11 |
Yeda Res & Dev |
Enzyme inhibitor in leukemia
|
|
US20060039949A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Nycz Jeffrey H |
Acetabular cup with controlled release of an osteoinductive formulation
|
|
US9145582B2
(en)
*
|
2004-09-22 |
2015-09-29 |
The Trustees Of The University Of Pennsylvania |
Microarray techniques for nucleic acid expression analyses
|
|
WO2006057997A2
(en)
|
2004-11-22 |
2006-06-01 |
Dyax Corp. |
Plasmin-inhibitory therapies
|
|
EP1814474B1
(en)
|
2004-11-24 |
2011-09-14 |
Samy Abdou |
Devices for inter-vertebral orthopedic device placement
|
|
US7642395B2
(en)
|
2004-12-28 |
2010-01-05 |
Kimberly-Clark Worldwide, Inc. |
Composition and wipe for reducing viscosity of viscoelastic bodily fluids
|
|
US20090124993A1
(en)
|
2005-02-17 |
2009-05-14 |
Burkly Linda C |
Treating neurological disorders
|
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
|
ES2432564T3
(en)
|
2005-05-10 |
2013-12-04 |
Biogen Idec Ma Inc. |
Treatment and evaluation of inflammatory disorders
|
|
US20060265352A1
(en)
*
|
2005-05-20 |
2006-11-23 |
International Business Machines Corporation |
Methods and apparatus for information integration in accordance with web services
|
|
US20100119489A1
(en)
*
|
2005-06-07 |
2010-05-13 |
Markus Stoffel |
Stimulation of Pancreatic Beta Cell Proliferation
|
|
WO2007019522A2
(en)
*
|
2005-08-04 |
2007-02-15 |
Carlos Lopez |
Reversal of adult onset disorders with granulocyte-colony stimulating factors
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
EP1973559B1
(en)
*
|
2005-11-23 |
2013-01-09 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for promoting bone growth
|
|
BRPI0707249A2
(en)
*
|
2006-01-27 |
2011-04-26 |
Tripath Imaging, Inc |
methods to identify patients most likely to have ovarian cancer and compositions for the same
|
|
US8273005B2
(en)
*
|
2006-02-02 |
2012-09-25 |
Samy Abdou |
Treatment of pain, neurological dysfunction and neoplasms using radiation delivery catheters
|
|
US7855057B2
(en)
*
|
2006-03-23 |
2010-12-21 |
Millipore Corporation |
Protein splice variant/isoform discrimination and quantitative measurements thereof
|
|
US7888044B2
(en)
|
2006-04-10 |
2011-02-15 |
Trustees Of Boston University |
Melanoma biomarker and methods of uses
|
|
CN103435683B
(en)
|
2006-06-16 |
2016-02-03 |
肿瘤疗法·科学股份有限公司 |
Cancer rejection antigen peptide from SPARC and the medicine containing this peptide
|
|
US20100284933A1
(en)
*
|
2006-10-16 |
2010-11-11 |
Biogen Idec Ma Inc. |
Biomarkers of Multiple Sclerosis
|
|
JP5601836B2
(en)
*
|
2006-11-08 |
2014-10-08 |
マクロジェニックス ウエスト， インコーポレイテッド |
TES7 and antibodies that bind to TES7
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
MY188973A
(en)
*
|
2006-12-18 |
2022-01-17 |
Acceleron Pharma Inc |
Activin-actrii antagonists and uses for treating anemia
|
|
US20100028332A1
(en)
*
|
2006-12-18 |
2010-02-04 |
Acceleron Pharma Inc. |
Antagonists of actriib and uses for increasing red blood cell levels
|
|
RU2473362C2
(en)
*
|
2007-02-01 |
2013-01-27 |
Акселерон Фарма Инк. |
ACTIVIN-ActRIIa-Fc ANTAGONISTS AND USE THEREOF FOR TREATING OR PREVENTING BREAST CANCER
|
|
TW202021980A
(en)
|
2007-02-02 |
2020-06-16 |
美商艾瑟勒朗法瑪公司 |
Variants derived from actriib and uses therefor
|
|
KR20180083967A
(en)
*
|
2007-02-09 |
2018-07-23 |
악셀레론 파마 인코포레이티드 |
Activin-actriia antagonists and uses for promoting bone growth in cancer patients
|
|
JP5572284B2
(en)
|
2007-02-27 |
2014-08-13 |
Ｊｘ日鉱日石エネルギー株式会社 |
Refrigerator oil and working fluid composition for refrigerator
|
|
US20080261298A1
(en)
*
|
2007-04-23 |
2008-10-23 |
Olympus American Inc. |
Method and device for the multiplex analysis of cells and tissues
|
|
EP2190448B1
(en)
|
2007-06-22 |
2016-04-20 |
Children's Medical Center Corporation |
Methods and uses thereof of a fragment of saposin a
|
|
CN107412734A
(en)
*
|
2007-09-18 |
2017-12-01 |
阿塞勒隆制药公司 |
Activin A CTRIIA antagonists and the purposes for reducing or suppressing FSH secretions
|
|
EP3381445B1
(en)
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
|
JO2913B1
(en)
*
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
|
|
DK2318028T3
(en)
*
|
2008-06-26 |
2020-05-04 |
Acceleron Pharma Inc |
ANTAGONISTS OF SOLVABLE ACTIVIN ACTIVIA AND APPLICATIONS TO INCREASE RED BLOOD CELL LEVELS
|
|
CA2729096C
(en)
*
|
2008-06-26 |
2020-04-28 |
Acceleron Pharma Inc. |
Methods for dosing an actriib antagonist and monitoring of treated patients
|
|
GB0813123D0
(en)
*
|
2008-07-17 |
2008-08-27 |
Symbian Software Ltd |
Method of searching
|
|
US20100015645A1
(en)
*
|
2008-07-18 |
2010-01-21 |
Kaohsiung Medical University |
Il-8 as biomarker for the detection of urolithiasis
|
|
WO2010011860A1
(en)
|
2008-07-23 |
2010-01-28 |
Diabetomics, Llc |
Methods for detecting pre-diabetes and diabetes
|
|
ES2949049T3
(en)
|
2008-08-14 |
2023-09-25 |
Acceleron Pharma Inc |
GDF traps
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
WO2010083034A1
(en)
|
2009-01-13 |
2010-07-22 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin
|
|
CN102482339B
(en)
|
2009-06-08 |
2015-06-17 |
阿塞勒隆制药公司 |
Methods for increasing thermogenic adipocytes
|
|
KR20210034684A
(en)
|
2009-06-12 |
2021-03-30 |
악셀레론 파마 인코포레이티드 |
TRUNCATED ActRIIB-FC FUSION PROTEINS
|
|
US8840889B2
(en)
|
2009-08-13 |
2014-09-23 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
WO2011056896A1
(en)
*
|
2009-11-03 |
2011-05-12 |
Acceleron Pharma Inc. |
Methods for treating fatty liver disease
|
|
AU2010322011B2
(en)
|
2009-11-17 |
2016-03-31 |
Acceleron Pharma Inc. |
ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
US8764806B2
(en)
|
2009-12-07 |
2014-07-01 |
Samy Abdou |
Devices and methods for minimally invasive spinal stabilization and instrumentation
|
|
EP2513137B1
(en)
|
2009-12-17 |
2018-02-28 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
|
EP2616554A1
(en)
|
2010-09-17 |
2013-07-24 |
President and Fellows of Harvard College |
Functional genomics assay for characterizing pluripotent stem cell utility and safety
|
|
CN103298832A
(en)
|
2010-11-08 |
2013-09-11 |
阿塞勒隆制药公司 |
ACTRIIA binding agents and uses thereof
|
|
EP2723865B1
(en)
|
2011-06-21 |
2019-03-27 |
Alnylam Pharmaceuticals, Inc. |
METHODS FOR DETERMINING ACTIVITY OF RNAi IN A SUBJECT
|
|
KR102103476B1
(en)
|
2011-06-24 |
2020-04-23 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
WO2013003112A1
(en)
|
2011-06-27 |
2013-01-03 |
The Jackson Laboratory |
Methods and compositions for treatment of cancer and autoimmune disease
|
|
US8845728B1
(en)
|
2011-09-23 |
2014-09-30 |
Samy Abdou |
Spinal fixation devices and methods of use
|
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
|
EP2780467B1
(en)
|
2011-11-14 |
2018-10-17 |
Alfasigma S.p.A. |
Assays and methods for selecting a treatment regimen for a subject with depression and methods for treatment
|
|
CA2860226C
(en)
|
2011-12-22 |
2022-10-18 |
Randolph S. Watnick |
Saposin-a derived peptides and uses thereof
|
|
CA2896951A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
US20130269537A1
(en)
|
2012-04-16 |
2013-10-17 |
Eugenio Minvielle |
Conditioning system for nutritional substances
|
|
US20130226240A1
(en)
|
2012-02-22 |
2013-08-29 |
Samy Abdou |
Spinous process fixation devices and methods of use
|
|
US20130269538A1
(en)
|
2012-04-16 |
2013-10-17 |
Eugenio Minvielle |
Transformation system for nutritional substances
|
|
US10219531B2
(en)
|
2012-04-16 |
2019-03-05 |
Iceberg Luxembourg S.A.R.L. |
Preservation system for nutritional substances
|
|
US9541536B2
(en)
|
2012-04-16 |
2017-01-10 |
Eugenio Minvielle |
Preservation system for nutritional substances
|
|
US20150027950A1
(en)
*
|
2012-03-27 |
2015-01-29 |
Marv Enterprises, LLC |
Treatment for atherosclerosis
|
|
EP3492095A1
(en)
|
2012-04-01 |
2019-06-05 |
Technion Research & Development Foundation Limited |
Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
|
|
US9429920B2
(en)
|
2012-04-16 |
2016-08-30 |
Eugenio Minvielle |
Instructions for conditioning nutritional substances
|
|
US9702858B1
(en)
|
2012-04-16 |
2017-07-11 |
Iceberg Luxembourg S.A.R.L. |
Dynamic recipe control
|
|
US9072317B2
(en)
|
2012-04-16 |
2015-07-07 |
Eugenio Minvielle |
Transformation system for nutritional substances
|
|
US9414623B2
(en)
*
|
2012-04-16 |
2016-08-16 |
Eugenio Minvielle |
Transformation and dynamic identification system for nutritional substances
|
|
US9436170B2
(en)
|
2012-04-16 |
2016-09-06 |
Eugenio Minvielle |
Appliances with weight sensors for nutritional substances
|
|
US9564064B2
(en)
|
2012-04-16 |
2017-02-07 |
Eugenio Minvielle |
Conditioner with weight sensors for nutritional substances
|
|
US8733631B2
(en)
|
2012-04-16 |
2014-05-27 |
Eugenio Minvielle |
Local storage and conditioning systems for nutritional substances
|
|
US9080997B2
(en)
|
2012-04-16 |
2015-07-14 |
Eugenio Minvielle |
Local storage and conditioning systems for nutritional substances
|
|
US9069340B2
(en)
|
2012-04-16 |
2015-06-30 |
Eugenio Minvielle |
Multi-conditioner control for conditioning nutritional substances
|
|
US9121840B2
(en)
|
2012-04-16 |
2015-09-01 |
Eugenio Minvielle |
Logistic transport system for nutritional substances
|
|
US9460633B2
(en)
|
2012-04-16 |
2016-10-04 |
Eugenio Minvielle |
Conditioner with sensors for nutritional substances
|
|
US9171061B2
(en)
|
2012-04-16 |
2015-10-27 |
Eugenio Minvielle |
Local storage and conditioning systems for nutritional substances
|
|
US9528972B2
(en)
|
2012-04-16 |
2016-12-27 |
Eugenio Minvielle |
Dynamic recipe control
|
|
US20140069838A1
(en)
|
2012-04-16 |
2014-03-13 |
Eugenio Minvielle |
Nutritional Substance Label System For Adaptive Conditioning
|
|
US9198767B2
(en)
|
2012-08-28 |
2015-12-01 |
Samy Abdou |
Devices and methods for spinal stabilization and instrumentation
|
|
US9320617B2
(en)
|
2012-10-22 |
2016-04-26 |
Cogent Spine, LLC |
Devices and methods for spinal stabilization and instrumentation
|
|
RU2678117C2
(en)
|
2012-11-02 |
2019-01-23 |
Селджин Корпорейшн |
Activin-actrii antagonists and uses thereof for treating bone and other disorders
|
|
EP3008229B1
(en)
|
2013-06-10 |
2020-05-27 |
President and Fellows of Harvard College |
Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
|
|
US10790062B2
(en)
|
2013-10-08 |
2020-09-29 |
Eugenio Minvielle |
System for tracking and optimizing health indices
|
|
AU2015212341A1
(en)
|
2014-02-03 |
2016-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of Casein kinase I inhibitors for depleting stem cells
|
|
CA2944903A1
(en)
|
2014-04-24 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
|
BR112016029226A2
(en)
|
2014-06-13 |
2017-10-17 |
Acceleron Pharma Inc |
methods and compositions for treating ulcers
|
|
EA036889B1
(en)
|
2014-06-19 |
2021-01-12 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
BIOMARKERS OF RESPONSE TO EZH2 INHIBITORS
|
|
US20170227541A1
(en)
|
2014-07-17 |
2017-08-10 |
The Trustees Of The University Of Pennsylvania |
Methods for using exosomes to monitor transplanted organ status
|
|
USD762081S1
(en)
|
2014-07-29 |
2016-07-26 |
Eugenio Minvielle |
Device for food preservation and preparation
|
|
WO2016057367A1
(en)
|
2014-10-06 |
2016-04-14 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
|
MA41052A
(en)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
TREATMENT OF CARDIOVASCULAR DISEASE USING ACTRII LIGAND TRAPS
|
|
CN113230384A
(en)
|
2014-10-09 |
2021-08-10 |
丹娜法伯癌症研究院 |
Multiple-variable IL-2 dosage regimen for treating immune disorders
|
|
TWI773117B
(en)
|
2014-12-03 |
2022-08-01 |
美商西建公司 |
Activin-actrii antagonists and uses for treating anemia
|
|
WO2016144673A1
(en)
|
2015-03-06 |
2016-09-15 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2 biomarkers predictive of pd-1 pathway inhibitor responses in esophagogastric cancers
|
|
KR101713421B1
(en)
*
|
2015-07-03 |
2017-03-09 |
울산대학교 산학협력단 |
Composition for diagnosing or treating brain neuronal disease
|
|
US10857003B1
(en)
|
2015-10-14 |
2020-12-08 |
Samy Abdou |
Devices and methods for vertebral stabilization
|
|
US10464977B2
(en)
*
|
2016-04-11 |
2019-11-05 |
University Of Maryland, Baltimore |
Histatin-5 based synthetic peptides and uses thereof
|
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
|
EP3515559B1
(en)
|
2016-09-20 |
2025-05-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of aml using usp10 biomarkers and modulators
|
|
US10973648B1
(en)
|
2016-10-25 |
2021-04-13 |
Samy Abdou |
Devices and methods for vertebral bone realignment
|
|
US10744000B1
(en)
|
2016-10-25 |
2020-08-18 |
Samy Abdou |
Devices and methods for vertebral bone realignment
|
|
US11078298B2
(en)
|
2016-10-28 |
2021-08-03 |
Banyan Biomarkers, Inc. |
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
|
|
EP3634496A4
(en)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
METHOD FOR RISING AWARENESS IN CANCER CELLS AGAINST T-CELL-MEDIATED KILLING BY MODULATING MOLECULAR SIGNAL PATHS
|
|
US20200339987A1
(en)
|
2017-11-09 |
2020-10-29 |
Alnylam Pharmaceuticals, Inc. |
Assays and methods for determining expression of the lect2 gene
|
|
EP3759125A4
(en)
|
2018-02-28 |
2021-12-08 |
Dana-Farber Cancer Institute, Inc. |
CANCER TREATMENT METHODS USING COMBINATIONS OF ANTI-BTNL2 BLOCKING AGENTS AND IMMUNE CHECKPOINTS
|
|
MX2020010094A
(en)
|
2018-04-06 |
2021-01-15 |
Dana Farber Cancer Inst Inc |
Kir3dl3 as an hhla2 receptor, anti-hhla2 antibodies, and uses thereof.
|
|
US11179248B2
(en)
|
2018-10-02 |
2021-11-23 |
Samy Abdou |
Devices and methods for spinal implantation
|
|
EP3883611A4
(en)
|
2018-11-19 |
2023-02-22 |
Dana-Farber Cancer Institute, Inc. |
USE OF BIOMARKERS FROM THE IRE1ALPHA-XBP1 SIGNALING PATHWAY TO MODULATE IMMUNE RESPONSES
|
|
EP3962529A4
(en)
|
2019-04-30 |
2023-11-01 |
Dana-Farber Cancer Institute, Inc. |
METHOD FOR CANCER TREATMENT USING ANTI-CX3CR1 AND IMMUNE CHECKPOINT BLOCKING REAGENTS COMBINATIONS
|
|
US12297244B2
(en)
|
2019-06-05 |
2025-05-13 |
Rensselaer Polytechnic Institute |
Systems and methods for inhibiting γ-secretase production of amyloid-β peptides
|
|
US12018279B2
(en)
|
2019-10-18 |
2024-06-25 |
The Trustees Of The University Of Pennsylvania |
Micro-engineered models of the human eye and methods of use
|
|
CN111161800B
(en)
*
|
2019-12-30 |
2021-05-07 |
云舟生物科技（广州）有限公司 |
Method, system, storage medium, and electronic device for diagnosing sequence of gene vector
|
|
EP4093513A4
(en)
|
2020-01-24 |
2024-05-08 |
Dana-Farber Cancer Institute, Inc. |
USE OF BIOMARKERS TO IMPROVE IMMUNOTHERAPY
|
|
JP2023548834A
(en)
|
2020-10-29 |
2023-11-21 |
エヴェロ バイオサイエンシズ，インコーポレーテッド |
Compositions containing spirulina components
|
|
CN112716971B
(en)
*
|
2021-01-19 |
2022-01-25 |
苏州大学 |
Application of lncRNA XR_595534.2 in the preparation of drugs for treating or preventing chronic pain
|
|
IL305575A
(en)
|
2021-03-02 |
2023-10-01 |
Dana Farber Cancer Inst Inc |
Methods of treating red blood cell disorders
|
|
US12467917B2
(en)
|
2021-03-16 |
2025-11-11 |
California Institute Of Technology |
Reconstructing human early embryogenesis in vitro with pluripotent stem cells
|
|
EP4074820A1
(en)
|
2021-04-16 |
2022-10-19 |
The Trustees of The University of Pennsylvania |
Micro-engineered models of the human eye and methods of use
|
|
WO2022251166A2
(en)
|
2021-05-25 |
2022-12-01 |
Evelo Biosciences, Inc. |
Bacterial compositions comprising soy hemoglobin
|
|
US20240280561A1
(en)
|
2021-06-08 |
2024-08-22 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
|
GB202208171D0
(en)
|
2022-06-01 |
2022-07-13 |
Institute Of Cancer Res |
Method
|
|
JP7437558B1
(en)
|
2023-07-20 |
2024-02-22 |
株式会社ファーマフーズ |
Information processing device, information processing method, and program
|
|
WO2025034542A1
(en)
|
2023-08-04 |
2025-02-13 |
Cornell University |
Gene signature panel predicting cancer response to immune checkpoint blockade and radiation therapy
|
|
WO2025169718A1
(en)
*
|
2024-02-09 |
2025-08-14 |
富士レビオ株式会社 |
Multimerized polypeptide, immunochromatographic strip, immunochromatographic device, immunochromatographic kit, and analyte detection method
|